Summary
Elevated glutamate concentrations are commonly observed in tumor patients, and glutamate was recently found to competitively inhibit the membrane transport of cystine. We therefore investigated the possibility that elevated plasma glutamate levels may damage the immune system. The experiments in this report demonstrate a link between the individual plasma glutamate level and the individual immunological reactivity as measured by mitogenic responses. This correlation has been analyzed in 39 colorectal carcinoma patients, 40 oat cell carcinoma patients, 24 large cell lung carcinoma patients, and 31 apparently healthy persons (blood donors). Blood cells from all three groups of tumor patients in comparison with cells from healthy persons produced markedly reduced mitogenic responses against PWM, and all three groups of tumor patients had on average significantly elevated plasma glutamic acid concentrations. Our analysis revealed a linear regression of the logarithm of the individual plasma glutamate levels (before therapeutic treatment) on the logarithm of the corresponding mitogenic reactivity against PWM for the entire population of 134 persons tested (correlation coefficient-0.80; level of significance P<0.00001). A statistically significant linear correlation with a similar regression equation was also observed in the group of the healthy blood donors (n=31); correlation coefficient-0.56; P<0.01), indicating that this correlation is universal and not dependent on the presence of a tumor. Mitogenically stimulated murine lymphocyte cultures revealed an inverse correlation between glutamate concentration and cell proliferation in response to the mitogens PHA and PWM.
Similar content being viewed by others
References
Ballantyne RM, McHenry EW (1949) Vitamin B6 and biotin in human cancer tissue. Cancer Res 9:689–691
Bannai S (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261:2256–2263
Beaton JR, McGanity WJ, McHenry EW (1951) Plasma glutamic acid levels in malignancy. Can Med Assoc J 65:219–221
Braun DP, Cobleigh MA, Harris JE (1980) Multiple concurrent immunoregulatory effects in cancer patients with depressed PHA induced lymphocyte DNA synthesis. Clin Immunol Immunophathol 17:89–101
Braunstein AE, Azarkh RM (1939) Transamination of 1- and damino acids in normal muscle and in malignant tumours. Nature 144:669–671
Collins PB, Johnson AH, Moriarty M (1980) T lymphocytes in human cancer. I. Mitogen-responsiveness of lymphocytes in cancer patients. Ir J Med Sci 149:301–303
De Jong B, Van der Meer IH (1984) Augmentation of Chinese hamster lymphocyte stimulation by cysteine. J Immunol Methods 68:55–60
Draper NR, Smith HM (1981) Applied regression analysis. 2nd edn. Wiley, New York
Fürst P, Bergström J, Hellström B, Vinnars E, Herfarth Ch, Klippel C, Merkel N, Schultis K, Elwyn D, Hardy M, Kinney J (1981) Amino acid metabolism in cancer. In: Kluthe R, Löhr GW (eds) Nutrition and metabolism in cancer. Thieme, Stuttgart New York, pp 75–89
Kluthe R, Adam G, Billmann U, Leins R, Wannemmacher M (1981) Serum amino acids and proteins in Hodgkin's disease. In: Kluthe R, Löhr GW (eds) Nutrition and metabolism in cancer. Thieme, Stuttgart New York, pp 95–100
Knauff HG, Leweling H (1981) Amino acid metabolism and supplementation in cancer. In: Kluthe R, Löhr GW (eds) Nutrition and metabolism in cancer. Thieme, Stuttgart New York, pp 101–110
Leroux M, Schindler L, Braun R, Doerr HW, Geisen HP, Kirchner H (1985) A whole-blood lymphoproliferation assay for measuring cellular immunity against Herpes viruses. J Immunol Methods 79:251–262
Makowske M, Christensen HN (1982) Contrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC. J Biol Chem 257:5663–5670
Miescher S, Whiteside TL, Carrel S, von Fliedner V (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferatíve responses of lymphocytes. J Immunol 136:1899–1907
Müller DS, Manger B, Zawatzky R, Kirchner H, Kalden JR (1984) Mitogen-induced γ-interferon production in peripheral blood lymphocytes from patients with colorectal tumors. Immunobiology 166:494–499
Ohmori H, Yamamoto I (1982) Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. I. 2-Mercaptoethanol-induced stimulation of the uptake of cystine, an essential amino acid. J Exp Med 155:1277–1290
Roth E, Lenzhofer R, Ollenschläger G, Funovics J (1984) Influence of parenteral nutrition on plasma amino acid levels of mammary carcinoma patients. Nutrition 8:408–411
Tötterman TH, Parthenais E, Häyry P, Timonen T, Saksela E (1980) Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. Cell Immunol 55:219–226
Vose BM, Vanky F, Klein E (1977) Human tumor-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumor-infiltrating blood and lymph-node lymphocytes with autologous tumor cells. Int J Cancer 20:895–902
Wanebo HJ, Jun MY, Strong EW, Oettgen H (1975) T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 130:445–448
Watanabc H, Bannai S (1987) Induction of cystine transport activity in mouse peritoneal macrophages. J Exp Med 165:628–640
Watkins SM (1973) The effects of surgery in lymphocyte transformation in patients with cancer. Clin Exp Immunol 14:69–76
White JM, Beaton JR, McHenry EW (1952) Observations on plasma glutamic acid. J Clin Lab Med 40:703–706
White JM, Ozawa G, Ross GAL, McHenry EW (1954) An effect of neoplasms on glutamic acid metabolism in the host. Cancer Res 14:508–512
Wu Ch, Bauer JM (1960) A study of free amino acids and of glutamine synthesis in tumor-bearing rats. Cancer Res 20:848–852
Yron I, Schickler M, Fisch B, Pinkas H, Ovadia J, Witz IP (1986) The immune system during the pre-cancer and the early cancer period. IL-2 production by PBL from postmenopausal women with and without endometrial carcinoma. Int J Cancer 38:331–338
Zenz M, Hilfrich J, Neuhaus R (1981) Gynecologic cancer and amino acid metabolism. In: Kluthe R, Löhr GW (eds) Nutrition and metabolism in cancer. Thieme, Stuttgart New York, pp 90–94
Author information
Authors and Affiliations
Additional information
These investigations have been supported in part by the Tumorzentrum Heidelberg/Mannheim (project Colorectal Carcinoma)
Rights and permissions
About this article
Cite this article
Dröge, W., Eck, H.P., Betzler, M. et al. Plasma glutamate concentration and lymphocyte activity. J Cancer Res Clin Oncol 114, 124–128 (1988). https://doi.org/10.1007/BF00417824
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00417824